ArticleOphthalmology and therapy2024

Efficacy and Safety of Biosimilar QL1207 vs. the Reference Aflibercept for Patients with Neovascular Age-Related Macular Degeneration: A Randomized Phase 3 Trial.

Bing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.